PLP2 and neoplasm: Zhou et al. [190] showed that miR-765, a negative regulator of proteolipid protein 2 (PLP2), was downregulated in an in vivo model of human uterine corpus endometrial cancer (UCEC), thus promoting tumor progression and epithelial mesenchymal transition (EMT).